Proteomes are an entire set of proteins which is expressed in genomes, and proteomics refers to the large-scale study of these proteomes, that include study of the functions and structure of proteins that can be used in diagnosis and treatment of various diseases, and in the process of drug discovery. Proteomics is used to analyze the interaction of proteins with each other, action of proteins in metabolic pathways, rate of the production of proteins, and the modification process of the proteins. Additionally, it is extensively applied in personalized medicine development, and marker identification for disease diagnosis. Global proteomics market is expected to grow significantly in the forecasted period due to the rising demand for personalized medicine and increasing investment in research and development activities, globally.
Explore Report at: https://www.psmarketresearch.com/market-analysis/proteomics-market
On the basis of reagents, the global proteomics market is segmented into microarray reagents, protein fractionation reagents, spectroscopy reagents, x-ray crystallography reagents, chromatography reagents, electrophoresis reagents, and immunoassay reagents. Protein fractionation reagents are expected to have a significant growth during the period 2017 – 2023, mainly due to its increased application in simplifying complex proteins and making the research processes easier.
Based on software and services, analytical laboratory services held largest share of the global proteomics market in 2016, mainly due to increasing research and development investments by the key players in the market and government. The global proteomics market finds application in drug discovery, clinical diagnosis, and other applications. Based on application, clinical diagnostics held the largest share of the global proteomics market in 2016, driven by increasing understanding of proteins and its application in the drug discovery.
Global Proteomics market is expected to grow significantly during the forecast period. Some of the major factors driving growth of the global proteomics market are rising demand for personalized medicine, increasing research and development investments, technological advancements, and availability of government and private funding. Personalized medicine is manufactured according to the treatment condition and helps in the better treatment and quick recovery of the patients. The benefits of the personalized medicine for the treatment of different types of cancer is further driving the growth of the global proteomics market. Moreover, the technological advancements in the field of proteomics are prompting the key market players to invest in the proteomics market. These technological advancements also lead to the more government as well as private funding which is likely to positively impact the growth of the global proteomics market. In 2015, grants were offered by National Cancer Institute for Clinical Proteomic Tumor Analysis Consortium (CPTAC) program that aimed to accelerate the understanding of the molecular basis of cancer.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/proteomics-market/report-sample
Some of the key players in the global proteomics market are Agilent Technologies Inc., Bruker Corporation, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Waters Corporation, Danaher Corporation, Luminex Corporation, and PerkinElmer Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)